Treatment of hepatocellular carcinoma: is there an optimal strategy?
about
Foxm1b transcription factor is essential for development of hepatocellular carcinomas and is negatively regulated by the p19ARF tumor suppressorHSVtk/GCV system on hepatoma carcinoma cells: Construction of the plasmid pcDNA3.1‑pAFP-TK and targeted killing effectDevelopments in liver transplantation.Synthesis and characterization of image-able polyvinyl alcohol microspheres for image-guided chemoembolization.Use of Ethanol in the Trans-Arterial Lipiodol Embolization (TAELE) of Intermediated-Stage HCC: Is This Safer than Conventional Trans-Arterial Chemo-Embolization (c-TACE)?Clinical significance of serum angiocidin levels in hepatocellular carcinoma.Lactoferrin-modified PEGylated liposomes loaded with doxorubicin for targeting delivery to hepatocellular carcinomaGrowth arrest and apoptosis of human hepatocellular carcinoma cells induced by hexamethylene bisacetamideDownregulation of KLF6 is an early event in hepatocarcinogenesis, and stimulates proliferation while reducing differentiation.Metallothionein expression is suppressed in primary human hepatocellular carcinomas and is mediated through inactivation of CCAAT/enhancer binding protein alpha by phosphatidylinositol 3-kinase signaling cascade.An Engineered Arginase FC Protein Inhibits Tumor Growth In Vitro and In Vivo.Chemoembolization with drug-eluting microspheres (DEM-TACE) for hepatocellular carcinoma: single-center review of safety and efficacySmad3 reduces susceptibility to hepatocarcinoma by sensitizing hepatocytes to apoptosis through downregulation of Bcl-2.Reduction of angiocidin contributes to decreased HepG2 cell proliferationThe Fox genes in the liver: from organogenesis to functional integration.Safety and effectiveness of chemoembolization with drug-eluting beads for advanced-stage hepatocellular carcinoma.Additive antitumour response to the rabbit VX2 hepatoma by combined radio frequency ablation and toll like receptor 9 stimulation.A report of 28 cases of 3-year follow-up after liver transplantation for advanced hepatocellular carcinoma.Stereotactic radiotherapy of hepatocellular carcinoma: preliminary results.
P2860
Q24624817-B49B3E8E-245B-4863-87E3-0A1B21B69988Q33828277-8EA62DE8-E06C-449E-9152-5754BCF444EFQ35596527-61B2E684-7135-4F39-A784-87416ADB9CFEQ35672442-6D7A24FB-F7BA-4F78-ADF5-007DC0B92300Q35674315-CB3EB2D9-945D-48BF-ACF9-95C7FD7BACABQ35956698-18B8B3F4-0A8F-464D-8440-5F1E840BBD5BQ35965943-82564570-B980-45CF-8E47-C3D8EB4AD33FQ36474687-8697E67B-547E-439E-9BA4-F259E59E7A5FQ36497062-E012AAB3-B142-482F-B3CF-20D714DAD787Q36512697-A526B53B-48A8-4D85-B994-BD67E07DDF4EQ36869275-9192E619-7724-4C41-AF70-422D01178AFBQ37031737-7CC44253-ED18-4C6F-A57B-E995122158A4Q37257648-E8B7A03C-B7BD-413D-9344-82D47EC4F4ECQ37298953-67FB86A0-2F1C-4577-8EF4-96B346926A7EQ37677914-CC651521-E2F4-4E98-89A4-605607FFB186Q38113503-426A8D9F-B9E1-427D-B3B9-FE5E23D73BD0Q38927132-98D9C800-881B-4704-872C-A432F1622452Q42025140-C2AA5A79-1188-4961-8273-A2B1FAE6213CQ50695738-45B7E707-5E1A-4F33-BFEA-8272B4F2F8C4
P2860
Treatment of hepatocellular carcinoma: is there an optimal strategy?
description
2003 nî lūn-bûn
@nan
2003 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Treatment of hepatocellular carcinoma: is there an optimal strategy?
@ast
Treatment of hepatocellular carcinoma: is there an optimal strategy?
@en
type
label
Treatment of hepatocellular carcinoma: is there an optimal strategy?
@ast
Treatment of hepatocellular carcinoma: is there an optimal strategy?
@en
prefLabel
Treatment of hepatocellular carcinoma: is there an optimal strategy?
@ast
Treatment of hepatocellular carcinoma: is there an optimal strategy?
@en
P1476
Treatment of hepatocellular carcinoma: is there an optimal strategy?
@en
P2093
Margarita Sala
María Varela
P304
P356
10.1016/S0305-7372(02)00123-8
P577
2003-04-01T00:00:00Z